TriMas (NASDAQ:TRS) Stock Rating Upgraded by Zacks Research

TriMas (NASDAQ:TRSGet Free Report) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

A number of other research firms have also recently commented on TRS. BWS Financial reissued a “buy” rating and set a $45.00 target price on shares of TriMas in a research report on Monday, March 2nd. KeyCorp reissued an “overweight” rating and set a $38.00 target price on shares of TriMas in a research report on Thursday, February 26th. Finally, Weiss Ratings cut shares of TriMas from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $41.50.

Get Our Latest Research Report on TRS

TriMas Stock Down 0.2%

NASDAQ:TRS traded down $0.10 during midday trading on Tuesday, reaching $41.51. 21,880 shares of the stock traded hands, compared to its average volume of 474,005. TriMas has a 12-month low of $23.65 and a 12-month high of $42.48. The business has a 50-day moving average of $37.02 and a two-hundred day moving average of $35.61. The company has a debt-to-equity ratio of 0.27, a quick ratio of 4.50 and a current ratio of 4.85. The stock has a market capitalization of $1.49 billion, a PE ratio of 1.73 and a beta of 0.58.

TriMas (NASDAQ:TRSGet Free Report) last posted its earnings results on Thursday, April 30th. The industrial products company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.24). TriMas had a net margin of 93.79% and a return on equity of 8.38%. The firm had revenue of $168.28 million for the quarter, compared to analysts’ expectations of $158.24 million. During the same period in the previous year, the company earned $0.46 EPS. The company’s revenue was up 10.3% on a year-over-year basis. TriMas has set its FY 2026 guidance at 1.500-1.70 EPS. On average, equities analysts forecast that TriMas will post 1.63 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in TRS. Capital International Investors purchased a new position in shares of TriMas in the third quarter worth $111,673,000. Jefferies Financial Group Inc. purchased a new position in shares of TriMas in the fourth quarter worth $55,036,000. Permian Investment Partners LP purchased a new position in shares of TriMas in the fourth quarter worth $29,192,000. SG Americas Securities LLC raised its holdings in shares of TriMas by 688.2% in the first quarter. SG Americas Securities LLC now owns 667,091 shares of the industrial products company’s stock worth $23,975,000 after buying an additional 582,452 shares during the last quarter. Finally, Alberta Investment Management Corp purchased a new position in shares of TriMas in the fourth quarter worth $16,605,000. Hedge funds and other institutional investors own 99.42% of the company’s stock.

TriMas Company Profile

(Get Free Report)

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Featured Articles

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.